Skip to content

Envoy Medical COCH Income Statement

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
$39K-15.2%$75K+78.6%$42K-25.0%$78K+14.7%$46K-22.0%
$313K+38.5%$211K+34.4%$203K+8.6%$234K-4.5%$226K+47.7%
-$274K-52.2%-$136K-18.3%-$161K-22.9%-$156K+11.9%-$180K-91.5%
-702.6%-311pp-181.3%+92.5pp-383.3%-149pp-200%+60.3pp-391.3%-232pp
$3.64M+32.5%$4.55M+84.3%$2.7M-2.1%$2.49M-4.1%$2.75M+16.4%
$164K-54.2%$96K-81.5%$405K+2.8%$361K-27.4%$358K+10.2%
$1.88M+3.2%$1.6M+10.7%$2.44M+44.5%$2.07M+30.3%$1.82M-13.5%
$6M+16.4%$6.46M+40.7%$5.75M+14.4%$5.15M+4.6%$5.15M+4.2%
-$5.96M-16.7%-$6.39M-40.4%-$5.71M-14.8%-$5.07M-4.5%-$5.11M-4.6%
-15,279.5%-4,177pp-8,513.3%+2,318pp-13,590.5%-4,712pp-6,500%+635pp-11,102.2%-2,824pp
$0-100%$471K+78.4%$624K+373%$495K+1,275%
$1.61M+1,375%-$201K-191%-$774K+21.7%-$620K-169%$109K+108%
-$4.35M+12.9%-$6.59M-42.6%-$6.48M-8.8%-$5.69M-44.2%-$5M+20.3%
-11,156.4%-291pp-8,781.3%+2,214pp-15,433.3%-4,790pp-7,294.9%-1,490pp-10,865.2%-238pp
-$0.08+72.4%-$0.26+35.0%-$0.35+10.3%-$0.32-10.3%-$0.29+29.3%
-$5.89M-16.6%-$6.31M-40.1%-$5.63M-14.4%-$4.99M-3.6%-$5.05M-4.0%
-15,092.3%-4,123pp-8,406.7%+2,310pp-13,409.5%-4,618pp-6,391%+683pp-10,969.6%-2,749pp
-$5.96M-16.7%-$6.39M-40.4%-$5.71M-14.8%-$5.07M-4.5%-$5.11M-4.6%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What is Envoy Medical's revenue?
Envoy Medical (COCH) generated $234.0K in revenue over the trailing twelve months, up 10.4% year over year.
Is Envoy Medical profitable?
Envoy Medical is not currently profitable: it reported a net loss of $23.1M over the trailing twelve months, a -9875.6% net margin.
What are Envoy Medical's profit margins?
Gross margin is -310.7% and operating margin is -9881.2%, with a -9875.6% net margin.
What is Envoy Medical's earnings per share?
Envoy Medical's diluted EPS over the trailing twelve months is $-1.01.
Where does Envoy Medical's income statement data come from?
Every line is extracted from Envoy Medical's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.